Elevance Health shareholders elect directors, approve executive pay, ratify E&Y, reject political spending proposal

Elevance Health, Inc.

Lewis Hay, III, Antonio F. Neri, and Ramiro G. Peru were elected as directors for three-year terms with over 183 million votes each.
Advisory vote on executive compensation approved with 179,754,212 for and 15,863,613 against.
Ratification of Ernst & Young LLP as independent auditor for 2024 passed with 186,378,524 votes for.
Shareholder proposal on annual political activity reporting rejected with only 9,977,190 votes in favor.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elevance Health, Inc. shareholders approved Advisory vote on the Company’s executive compensation at the 2024-05-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

Advisory vote on the Company’s executive compensation. The advisory vote on the compensation of the Company’s named executive officers was approved based upon the following votes:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elevance Health, Inc. shareholders rejected Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations at the 2024-05-15 meeting.

Outcome: failed
Meeting: 2024-05-15

Exact text from the filing

Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations. The shareholder proposal requesting annual political activity reporting from third parties prior to the Company donating to the organization was not approved based upon the following votes:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elevance Health, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

Election of Directors. The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2027 based on the following votes:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elevance Health, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP at the 2024-05-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2024-05-15

Exact text from the filing

Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2024 was ratified based upon the following votes:

View on SEC.gov

210 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Elevance Health, Inc. filing history →

Source: SEC EDGAR

accession 0001156039-24-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.